Citi upgraded iRhythm to Buy from Neutral with a $110 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IRTC:
- iRhythm announces results of new retrospective analysis on ECG monitoring
- New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
- iRhythm price target lowered to $108 from $140 at Needham
- iRhythm price target lowered to $88 from $116 at Canaccord
- iRhythm price target lowered to $85 from $100 at Citi